TopNews

CVSA Sets Operation Safe Driver Week in October

July 27, 2017

SHARING TOOLS        | Print Subscribe
Image via CVSA
Image via CVSA

The Commercial Vehicle Safety Alliance’s Operation Safe Driver Week has been scheduled for Oct. 15 to 21, with law enforcement across the country identifying unsafe driving behavior in commercial and passenger vehicles.

Law enforcement personnel will be issuing warnings and citations for drivers, targeting unsafe driver behaviors that make up the leading cause of crashes. The Federal Motor Carrier Safety Administration cites driver behavior as the critical reason for more than 88% of large truck crashes and 93% of passenger vehicle crashes.

The Operation Safe Driver Program was created to help reduce the number of crashes, deaths, and injuries involving commercial vehicles due to unsafe driving behaviors. During the week, there will be increased commercial vehicle and passenger vehicle traffic enforcement.

Dangerous driving behaviors targeted by the event will be speeding, distracted driving, texting, failure to use a seatbelt, following too closely, improper lane change, failure to obey traffic control devices and other similar violations.

Operation Safe Driver Week is sponsored by CVSA, in partnership with FMCSA and with support from industry and transportation safety organizations, and aims to help improve the behavior of all drivers operating in an unsafe manner – either in or around a commercial vehicle– through educational and traffic enforcement strategies to address individuals exhibiting high-risk driving behaviors.

Comment On This Story

Name:  
Email:  
Comment: (Maximum 2000 characters)  
Leave this field empty:
* Please note that every comment is moderated.

Newsletter

We offer e-newsletters that deliver targeted news and information for the entire fleet industry.

GotQuestions?
sponsored by
sponsor logo

ELDs and Telematics

Scott Sutarik from Geotab will answer your questions and challenges

View All
GotQuestions?

Sleeper Cab Power

Steve Carlson from Xantrex will answer your questions and challenges

View All